Dysmorphic features
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Zinc finger protein Zbtb20 is essential for postnatal survival and glucose homeostasis.
|
19273596 |
2009 |
Overgrowth
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
Zinc finger protein Zbtb20 is essential for postnatal survival and glucose homeostasis.
|
19273596 |
2009 |
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
We validated ZBTB20, CELF2, PARD3, AKAP13 and WAC, which were identified by our screens in multiple cancer types, as new tumor suppressor genes in prostate cancer.
|
28319090 |
2017 |
Fatty Liver Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
We suggest ZBTB20 is an essential regulator of hepatic lipogenesis and may be a therapeutic target for the treatment of fatty liver disease.
|
28327662 |
2017 |
Primrose syndrome
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome.
|
25017102 |
2014 |
Primrose syndrome
|
0.770 |
Biomarker
|
disease |
CTD_human |
We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome.
|
25017102 |
2014 |
Primrose syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome.
|
25017102 |
2014 |
Primrose syndrome
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome.
|
25017102 |
2014 |
Primrose syndrome
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
We report that missense mutations in ZBTB20, residing within the 3q13.31 microdeletion syndrome critical region, underlie Primrose syndrome.
|
25017102 |
2014 |
Intellectual Disability
|
0.120 |
GeneticVariation
|
group |
BEFREE |
We report a boy with intellectual disability carrying two de novo missense mutations in the last exon of ZBTB20 (Ser616Phe and Gly741Arg; both previously unreported).
|
27061120 |
2016 |
Malignant neoplasm of stomach
|
0.430 |
Biomarker
|
disease |
CTD_human |
We identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).
|
22037551 |
2011 |
Malignant neoplasm of stomach
|
0.430 |
GeneticVariation
|
disease |
GWASDB |
We identified two new susceptibility loci for non-cardia gastric cancer at 5p13.1 (rs13361707 in the region including PTGER4 and PRKAA1; odds ratio (OR) = 1.41; P = 7.6 × 10(-29)) and 3q13.31 (rs9841504 in ZBTB20; OR = 0.76; P = 1.7 × 10(-9)).
|
22037551 |
2011 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Using liver tissues from transgenic mice in which microRNA122 is functionally silenced, an orthotopic xenograft tumour model, and human clinical samples, we further demonstrate that a microRNA122/CUX1/microRNA214/ZBTB20 pathway regulates AFP expression.
|
21654638 |
2011 |
Liver carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Univariate and multivariate analyses revealed that ZBTB20 overexpression was an independent prognostic factor for HCC.
|
21702992 |
2011 |
Autistic Disorder
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Two ZBTB20 single nucleotide variants, located at the N-terminal and central regions of the protein and potentially conferring autism risk, altered dendritic spine morphology.
|
30281617 |
2018 |
Developmental Disabilities
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Through an exome sequencing approach (as part of the Deciphering Developmental Disorders [DDD] study) we have identified five unrelated individuals with previously unreported, de novo ZBTB20 pathogenic missense variants.
|
30637921 |
2019 |
Malignant neoplasm of stomach
|
0.430 |
GeneticVariation
|
disease |
BEFREE |
Those subjects with both the risk alleles MUC1 rs9841504 and ZBTB20 rs4072037 had a greater than 3-fold increased risk of gastric cancer.
|
27127881 |
2016 |
Stomach Carcinoma
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Those subjects with both the risk alleles MUC1 rs9841504 and ZBTB20 rs4072037 had a greater than 3-fold increased risk of gastric cancer.
|
27127881 |
2016 |
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, our results highlight an important role for ZBTB20 in controlling NSCLC development, which might be helpful to identify potential therapeutic targets for its treatment.
|
25311537 |
2014 |
Malignant neoplasm of stomach
|
0.430 |
Biomarker
|
disease |
BEFREE |
Therefore, our findings emphasize an important role for ZBTB20 in controlling gastric cancer development, which is helpful to identify potential therapeutic targets for its treatment.
|
31556767 |
2019 |
Stomach Carcinoma
|
0.130 |
Biomarker
|
disease |
BEFREE |
Therefore, our findings emphasize an important role for ZBTB20 in controlling gastric cancer development, which is helpful to identify potential therapeutic targets for its treatment.
|
31556767 |
2019 |
Tumor Cell Invasion
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
The restored ZBTB20 expression partially rescued the miR-758-5p-induced inhibition of GBM cell proliferation, migration, and invasion.
|
30099442 |
2018 |
Glioblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The restored ZBTB20 expression partially rescued the miR-758-5p-induced inhibition of GBM cell proliferation, migration, and invasion.
|
30099442 |
2018 |
Glioblastoma Multiforme
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The restored ZBTB20 expression partially rescued the miR-758-5p-induced inhibition of GBM cell proliferation, migration, and invasion.
|
30099442 |
2018 |
Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
The regulating associations between LINC00641, miR-378a, and ZBTB20 were investigated in AML cells using the Luciferase reporter assays and RT-PCR assays RESULTS: We found that LINC00641 was highly expressed in AML specimens and cell lines.
|
31539138 |
2019 |